These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7818809)

  • 1. T-cell proliferation to subinfectious SIV correlates with lack of infection after challenge of macaques.
    Clerici M; Clark EA; Polacino P; Axberg I; Kuller L; Casey NI; Morton WR; Shearer GM; Benveniste RE
    AIDS; 1994 Oct; 8(10):1391-5. PubMed ID: 7818809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated exposure of rhesus macaques to low doses of simian immunodeficiency virus (SIV) did not protect them against the consequences of a high-dose SIV challenge.
    Dittmer U; Stahl-Hennig C; Coulibaly C; Nisslein T; Lüke W; Fuchs D; Bodemer W; Petry H; Hunsmann G
    J Gen Virol; 1995 Jun; 76 ( Pt 6)():1307-15. PubMed ID: 7782761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization of macaques with single-cycle simian immunodeficiency virus (SIV) stimulates diverse virus-specific immune responses and reduces viral loads after challenge with SIVmac239.
    Evans DT; Bricker JE; Sanford HB; Lang S; Carville A; Richardson BA; Piatak M; Lifson JD; Mansfield KG; Desrosiers RC
    J Virol; 2005 Jun; 79(12):7707-20. PubMed ID: 15919923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination with the Conserved Caveolin-1 Binding Motif in Human Immunodeficiency Virus Type 1 Glycoprotein gp41 Delays the Onset of Viral Infection and Provides Partial Protection in Simian/Human Immunodeficiency Virus-Challenged Cynomolgus Macaques.
    Hovanessian AG; Soundaramourty C; Benferhat R; Le Grand R; Dereuddre-Bosquet N; Krust B; Estaquier J
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-mediated immunity to low doses of SIVsm in cynomolgus macaques did not confer protection against mucosal rechallenge.
    Mäkitalo B; Böttiger1 P; Biberfeld G; Thorstensson R
    Vaccine; 2000 Sep; 19(2-3):298-307. PubMed ID: 10930685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal exposure to subinfectious doses of SIV primes gut-associated antibody-secreting cells and T cells: lack of enhancement by nonneutralizing antibody.
    Polyanskaya N; Bergmeier LA; Sharpe SA; Cook N; Leech S; Hall G; Dennis M; ten Haaft P; Heeney J; Manca F; Lehner T; Cranage MP
    Virology; 2001 Jan; 279(2):527-38. PubMed ID: 11162808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breadth and magnitude of antigen-specific antibody responses in the control of plasma viremia in simian immunodeficiency virus infected macaques.
    Pahar B; Kenway-Lynch CS; Marx P; Srivastav SK; LaBranche C; Montefiori DC; Das A
    Virol J; 2016 Dec; 13(1):200. PubMed ID: 27903274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrarectal inoculation of macaques by the simian immunodeficiency virus, SIVmne E11S: CD4+ depletion and AIDS.
    Kuller L; Benveniste RE; Tsai CC; Clark EA; Polacino P; Watanabe R; Overbaugh J; Katze MG; Morton WR
    J Med Primatol; 1994 Sep; 23(7):397-409. PubMed ID: 7731030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted lymph-node immunization with whole inactivated simian immunodeficiency virus (SIV) or envelope and core subunit antigen vaccines does not reliably protect rhesus macaques from vaginal challenge with SIVmac251.
    Lü X; Kiyono H; Lu D; Kawabata S; Torten J; Srinivasan S; Dailey PJ; McGhee JR; Lehner T; Miller CJ
    AIDS; 1998 Jan; 12(1):1-10. PubMed ID: 9456249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infection of cynomolgus monkeys with HIV-2 protects against pathogenic consequences of a subsequent simian immunodeficiency virus infection.
    Putkonen P; Thorstensson R; Albert J; Hild K; Norrby E; Biberfeld P; Biberfeld G
    AIDS; 1990 Aug; 4(8):783-9. PubMed ID: 1979745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-mediated immune response of macaques immunized with low doses of simian immunodeficiency virus (SIV).
    Dittmer U; Spring M; Petry H; Nisslein T; Rieckmann P; Lüke W; Stahl-Hennig C; Hunsmann G; Bodemer W
    J Biotechnol; 1996 Jan; 44(1-3):105-10. PubMed ID: 8717393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
    Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional analyses of natural killer cells in macaques infected with neurovirulent simian immunodeficiency virus.
    Shieh TM; Carter DL; Blosser RL; Mankowski JL; Zink MC; Clements JE
    J Neurovirol; 2001 Feb; 7(1):11-24. PubMed ID: 11519478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similar abnormalities of idiotype and immunoglobulin light chain expression and of cell-mediated cytotoxicity in HIV-infected humans and simian immunodeficiency virus (SIV)-infected rhesus macaques.
    Grant MD; Whaley MD; Mayne A; Hoffmann GW; Ansari AA
    Immunol Cell Biol; 1996 Feb; 74(1):38-44. PubMed ID: 8934652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypervariable epitope constructs representing variability in envelope glycoprotein of SIV induce a broad humoral immune response in rabbits and rhesus macaques.
    Meyer D; Anderson DE; Gardner MB; Torres JV
    AIDS Res Hum Retroviruses; 1998 Jun; 14(9):751-60. PubMed ID: 9643375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged clinical latency and survival of macaques given a whole inactivated simian immunodeficiency virus vaccine.
    Hirsch VM; Goldstein S; Hynes NA; Elkins WR; London WT; Zack PM; Montefiori D; Johnson PR
    J Infect Dis; 1994 Jul; 170(1):51-9. PubMed ID: 8014520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model.
    Suh YS; Park KS; Sauermann U; Franz M; Norley S; Wilfingseder D; Stoiber H; Fagrouch Z; Heeney J; Hunsmann G; Stahl-Hennig C; Sung YC
    Vaccine; 2006 Mar; 24(11):1811-20. PubMed ID: 16274888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization of macaques with live simian human immunodeficiency virus (SHIV) vaccines conferred protection against AIDS induced by homologous and heterologous SHIVs and simian immunodeficiency virus.
    Kumar A; Mukherjee S; Shen J; Buch S; Li Z; Adany I; Liu Z; Zhuge W; Piatak M; Lifson J; McClure H; Narayan O
    Virology; 2002 Sep; 301(2):189-205. PubMed ID: 12359422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against mucosal SIVsm challenge in macaques infected with a chimeric SIV that expresses HIV type 1 envelope.
    Quesada-Rolander M; Mäkitalo B; Thorstensson R; Zhang YJ; Castaños-Velez E; Biberfeld G; Putkonen P
    AIDS Res Hum Retroviruses; 1996 Jul; 12(11):993-9. PubMed ID: 8827215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity of helper T-cells generated from macaques infected with attenuated simian immunodeficiency virus.
    Dittmer U; Feldmann G; Sauermann U; Spirng M; Uberla K; Stahl-Hennig C; Hunsmann G
    J Gen Virol; 1998 Jul; 79 ( Pt 7)():1801-7. PubMed ID: 9680145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.